Nonthyroidal Illness Syndrome in Ischaemic Stroke Patients is Associated with Increased Mortality

Abstract

Background Results of studies on associations between triiodothyronine serum levels and mortality after acute ischemic stroke (AIS) are inconsistent. Therefore, the aim of this prospective study was to evaluate links between serum levels of thyroid axis associated hormones and all-cause mortality during 1 year after AIS.

Methods and results This study involved 255 patients with AIS. Patients were divided into two groups: those who survived 1 year after their index stroke and those who not, and by quartiles of free triiodothyronine (FT3) and ΔFT3 (difference between basal FT3 and repeated FT3 on discharge) hormone serum concentrations. To assess serum levels of thyroid stimulating hormone (TSH), FT3 and free tetraiodothyronine (FT4), venous blood was taken from all included patients on admission to hospital. On discharge, blood tests were repeated for 178 (69.8%) patients. Study endpoints were overall mortality within 30, 90 and 365 days after AIS.

Results Compared with the survivals, those who died had significantly lower mean FT3, FT3/FT4 ratio in all periods and lower median TSH within 30 days. Higher FT3 serum levels versus lower, even after adjustment for included important variables, remained significant for lower odds of death within 365 days after AIS (OR=0.57; 95% CI: 0.33–0.97, p=0.04), but added insignificant additional predictive value to the NIHSS score or age. Kaplan–Meier survival curves demonstrated that the first FT3 quartile was significantly associated with increased mortality compared with all other quartiles within 365 days after AIS. With ΔFT3 quartiles no such association was found.

Conclusions. Higher FT3 levels on admission versus lower are significantly associated with lower mortality within 365 days after AIS. FT3 serum levels changes over time didn’t show any association with mortality within first year.

Key words

free triiodothyronine - acute ischaemic stroke - death

Publication History

Received: 17 December 2018
Received: 06 May 2019

Accepted: 07 May 2019

Article published online:
03 June 2019

• References

• 1 Policies OEOoHSa. Lithuania: Country Health Profile. 2017, State of Health in the EU. In Paris/European Observatory on Health Systems and Policies. OECD Publishing; 2017
• 2 [Anonymous]. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459-1544 doi:10.1016/s0140-6736(16)31012-1
• 3 Hankey GJ, Spiesser J, Hakimi Z. et al. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 2007; 68: 1583-1587
• 4 Konig IR, Ziegler A, Bluhmki E. et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008; 39: 1821-1826
• 5 Makris K, Haliassos A, Chondrogianni M. et al. Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research. Crit Rev Clin Lab Sci 2018; 55: 294-328
• 6 Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert review of neurotherapeutics 2015; 15: 315-326
• 7 Jiang X, Xing H, Wu J. et al. Prognostic value of thyroid hormones in acute ischemic stroke - a meta analysis. Sci Rep 2017; 7: 16256
• 8 Fliers E, Bianco AC, Langouche L. et al. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol 2015; 3: 816-825
• 9 De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999; 84: 151-164 doi:10.1210/jcem.84.1.5364
• 10 Wajner SM, Maia AL. New insights toward the acute non-thyroidal illness syndrome. front endocrinol (Lausanne) 2012; 3: 8 doi:10.3389/fendo.2012.00008
• 11 Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 2006; 116: 2571-2579 doi:10.1172/jci29812
• 12 Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 2011; 32: 670-693 doi:10.1210/er.2011-0007
• 13 O'Keefe LM, Conway SE, Czap A. et al. Thyroid hormones and functional outcomes after ischemic stroke. Thyroid Res 2015; 8: 9
• 14 Neidert S, Katan M, Schuetz P. et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 2011; 269: 420-432
• 15 Ambrosius W, Kazmierski R, Gupta V. et al. Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke. Exp Clin Endocrinol Diabetes 2011; 119: 139-143
• 16 Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10: 232-274 doi:10.1210/edrv-10-3-232
• 17 Burkauskas J, Brozaitiene J, Staniute M. et al. Gene-Environment Interactions Connecting Low Triiodothyronine Syndrome and Outcomes of Cardiovascular Disease (GET-VASC): study protocol. Biological Psychiatry and Psychopharmacology. 2014; 16: 66-73
• 18 Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94: 167-173
• 19 Hatano S. Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ 1976; 54: 541-553
• 20 Langouche L, Vander Perre S, Marques M. et al. Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: A randomized, controlled clinical study. The Journal of Clinical Endocrinology & Metabolism 2013; 98: 1006-1013
• 21 Al-Subaihi AA. Sample size determination. Influencing factors and calculation strategies for survey research. Saudi Med J 2003; 24: 323-330
• 22 Chen Z, Venkat P, Seyfried D. et al. Brain-Heart Interaction: Cardiac complications after stroke. Circ Res 2017; 121: 451-468
• 23 Silver FL, Norris JW, Lewis AJ. et al. Early mortality following stroke: A prospective review. Stroke 1984; 15: 492-496
• 24 Davalos A, Ricart W, Gonzalez-Huix F. et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996; 27: 1028-1032
• 25 Boelen A, Wiersinga WM, Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 2008; 18: 123-129 doi:10.1089/thy.2007.0253
• 26 Ma L, Zhu D, Jiang Y. et al. Low triiodothyronine: A new facet of inflammation in acute ischemic stroke. Clin Chim Acta 2016; 458: 63-67
• 27 Sadana P, Coughlin L, Burke J. et al. Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation. J Neurol Sci 2015; 354: 37-45
• 28 Sabbaghziarani F, Mortezaee K, Akbari M. et al. Stimulation of neurotrophic factors and inhibition of proinflammatory cytokines by exogenous application of triiodothyronine in the rat model of ischemic stroke. Cell Biochem Funct 2017; 35: 50-55
• 29 Baek JH, Chung PW, Kim YB. et al. Favorable influence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J 2010; 57: 23-29
• 30 You J, Feng L. Cerebral Ischemic Postconditioning Plays a Neuroprotective Role through Regulation of Central and Peripheral Glutamate. 2018; 2018: 6316059 doi:10.1155/2018/6316059
• 31 Iervasi G, Pingitore A, Landi P. et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107: 708-713
• 32 Iltumur K, Olmez G, Ariturk Z. et al. Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome. Crit Care 2005; 9: R416-R424
• 33 Kim JG, Shin H. The value of decreased thyroid hormone for predicting mortality in adult septic patients: a systematic review and meta-analysis 2018; 8: 14137 doi:10.1038/s41598-018-32543-7
• 34 Russell W, Harrison RF, Smith N. et al. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab 2008; 93: 2300-2306